Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treatment of internal diseases and preparation method thereof

A composition and drug technology, applied in the direction of drug combination, metabolic disease, medical formula, etc., can solve the problems of high cost, high risk, patient pain, etc., and achieve the effect of convenient taking, good curative effect, and improved quality of life

Inactive Publication Date: 2016-03-16
叶宗耀
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, once chronic renal failure develops, neither Western medicine nor Chinese medicine has a good solution. In the end, dialysis and kidney replacement are the only options. Not only are the risks high, the cost is high, and the patient is extremely painful.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] The pharmaceutical composition of Example 1 of the present invention includes the following preparation raw materials in parts by weight: 5 parts of total flavonoids of leaves of Moringa oleifera, 6 parts of astragalus, 9 parts of Codonopsis pilosula, 3 parts of safflower, 3 parts of Rhizoma Chuanxiong, 5 parts of Coptis chinensis, 1 part of Angelica dahurica, 9 parts of rehmannia, 3 parts of cucumber seeds and 1 part of licorice.

[0036] The preparation method is as follows:

[0037] S1: Preparation of total flavonoids from Moringa oleifera leaves:

[0038] A: take Moringa leaf, dry, pulverize, cross 45 mesh sieves, obtain Moringa leaf powder;

[0039] B: Take the Moringa oleifera leaf powder obtained in step A, add petroleum ether, reflux and degrease 3 times at 68° C. for 6 hours each time, filter, remove the filtrate, and dry the filter residue to obtain a dry filter residue;

[0040] C: Add 70% ethanol to the dried filter residue obtained in step B, process it a...

Embodiment 2

[0045] The pharmaceutical composition of Example 2 of the present invention includes the following preparation raw materials in parts by weight: 30 parts of total flavonoids of leaves of Moringa oleifera, 30 parts of Astragalus membranaceus, 30 parts of Codonopsis pilosula, 20 parts of safflower, 20 parts of Rhizoma Chuanxiong, 20 parts of Coptis chinensis, 20 parts of Angelica dahurica, Rehmannia glutinosa 15 parts, cucumber seeds 20 parts and licorice 15 parts.

[0046] The preparation method is the same as in Example 1.

Embodiment 3

[0048] The pharmaceutical composition of Example 3 of the present invention includes the following preparation raw materials in parts by weight: 20 parts of total flavonoids of leaves of Moringa oleifera, 20 parts of Astragalus membranaceus, 20 parts of Codonopsis pilosula, 14 parts of safflower, 18 parts of Rhizoma Chuanxiong, 14 parts of Coptis chinensis, 10 parts of Angelica dahurica, Rehmannia glutinosa 10 parts, cucumber seeds 15 parts and licorice 10 parts.

[0049] The preparation method is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of traditional Chinese medicine, and relates to a pharmaceutical composition for treatment of internal diseases and a preparation method thereof. The pharmaceutical composition includes the following raw materials in parts by weight: 5-30 parts of total flavones of moringa oleifera leaf, 6-30 parts of radix astragali, 9-30 parts of codonopsis pilosula, 3-20 parts of safflower, 3-20 parts of ligusticum wallichii, 5-20 parts of coptis chinensis, 1-20 parts of radix angelicae, 9-15 parts of radix rehmanniae praeparata, 3-20 parts of cucumber seeds, and 1-15 parts of liquorice. The pharmaceutical composition is reasonable in formula and strong in synergism, is used as a drug for treatment for internal diseases for compatibility use, and achieves extremely significant effects through clinical verifications.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine, in particular to a pharmaceutical composition for treating internal diseases and a preparation method thereof. Background technique [0002] Diabetic nephropathy is the most serious and harmful chronic complication caused by diabetes. It is one of the manifestations of systemic microangiopathy in diabetes. The clinical features are proteinuria, progressive renal damage, hypertension, edema, and severe renal function in the late stage. Failure is one of the leading causes of death in diabetic patients. At present, Western medicine treatment mostly starts with diet control, strengthened blood sugar control, lowering blood pressure, adjusting lipid metabolism, etc., or adopts dialysis, kidney transplantation and other treatment methods. Although effective, it brings heavy economic burden to patients. With experience, the effect is obvious, no need for long-term medication, no dependence,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/804A61P3/10A61P13/12
CPCA61K36/185A61K9/4858A61K36/232A61K36/236A61K36/286A61K36/344A61K36/42A61K36/481A61K36/484A61K36/718A61K36/804A61K2236/331A61K2236/333A61K2236/39A61K2236/55
Inventor 叶宗耀邹锦新
Owner 叶宗耀
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com